UK biotech group raises £48mn for Alzheimer’s research

UCL spinout company AstronauTx, aiming to develop novel treatments for Alzheimer’s disease and other neurodegenerative disorders, has closed a £48m ($61m) Series A financing.

Read: Financial Times, More: UCL News